Altimmune to participate at two upcoming conferences

Gaithersburg, md., may 01, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that dr. scott harris, chief medical officer at altimmune, will present on behalf of the company at the following two upcoming conferences:
ALT Ratings Summary
ALT Quant Ranking